Comparative Mortality Risk of Anemia Management Practices in Incident Hemodialysis Patients

2010 ◽  
Vol 2010 ◽  
pp. 249-250
Author(s):  
R. Garrick
JAMA ◽  
2010 ◽  
Vol 304 (1) ◽  
pp. 41 ◽  
Author(s):  
Yi Zhang ◽  
Mae Thamer ◽  
Dennis Cotter

JAMA ◽  
2010 ◽  
Vol 304 (1) ◽  
pp. 41
Author(s):  
M. Alan Brookhart ◽  
Jerry Avorn ◽  
Wolfgang Winkelmayer

2021 ◽  
Author(s):  
Diego A Sandoval ◽  
Inés Rama ◽  
María Quero ◽  
Miguel Hueso ◽  
Francisco Gómez ◽  
...  

Abstract Hemodialysis patients present more morbidity and mortality risk in coronavirus disease 2019. In patients who may develop severe symptoms the process called “viral sepsis” seems to be a crucial mechanism. In those cases, the hemodialysis procedure provides an excellent tool to explore the benefit of some extracorporeal therapies. We reported the outcome of 4 hemodialysis patients with severe COVID-19 treated with Seraph®100 hemoperfusion device. Three of four cases presented a good clinical response after hemoperfusion. In conclusion, the treatment with Seraph®100 device may be a simultaneous treatment to improve the hemodialysis patients with severe SARS-CoV-2.


2012 ◽  
Vol 7 (9) ◽  
pp. 1454-1460 ◽  
Author(s):  
Mari Suzuki ◽  
Takahashi Hiroshi ◽  
Toru Aoyama ◽  
Miho Tanaka ◽  
Hideki Ishii ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document